GridAI Technologies (GRDX) Total Debt (2015 - 2025)

GridAI Technologies' (GRDX) quarterly Total Debt came in at $6.2 million in Q4 2025, up 792.86% on a QoQ basis from $700000.0 in Q3 2025.

GridAI Technologies (GRDX) Total Debt (2015 - 2025) Analysis & Trends

GridAI Technologies (GRDX) has 8 years of Total Debt data on file, last reported at $6.2 million in Q4 2025.

Quarterly Total Debt changed N/A year-over-year to $6.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.2 million (changed N/A YoY) and the FY2025 annual result came in at $6.2 million, changed N/A from the prior year.
Total Debt improved to $6.2 million in Q4 2025, from $700000.0 in the prior quarter.
In the past five years, Total Debt ranged from a high of $6.4 million in Q1 2024 to a low of $347082.0 in Q1 2021.
A 3-year average of $2.5 million and a median of $700000.0 in 2025 frame the typical range for Total Debt.
Annual changes were most pronounced in 2021 — Total Debt gained 24.13% — and 2025, when it tumbled 89.06%.
Tracing GRDX's Total Debt over 3 years: stood at $347082.0 in 2021, then surged by 1743.34% to $6.4 million in 2024, then slipped by 2.31% to $6.2 million in 2025.
The last three Total Debt figures came in at $6.2 million (Q4 2025), $700000.0 (Q3 2025), and $700000.0 (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Vertex Pharmaceuticals	139.69 Bn	131.84 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.46 Bn	78.47 Bn	3.93 Bn	1.99 Bn
3	Argenx Se	65.62 Bn	60.44 Bn	1.37 Bn	-
4	Moderna	58.37 Bn	53.24 Bn	52.00 Mn	591.00 Mn
5	BeOne Medicines	42.17 Bn	37.07 Bn	1.53 Bn	1.07 Bn
6	Alnylam Pharmaceuticals	31.73 Bn	28.43 Bn	992.69 Mn	-
7	BioNTech SE	28.27 Bn	9.87 Bn	668.28 Mn	770.36 Mn
8	Insmed	27.58 Bn	26.42 Bn	358.27 Mn	546.77 Mn
9	Royalty Pharma	27.23 Bn	26.40 Bn	-	9.34 Bn
10	GridAI Technologies	6.06 Mn	6.06 Mn	-	6.25 Mn

Download Data